Polar Asset Management Partners’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,688,193
Closed -$142K 760
2025
Q1
$142K Hold
2,688,193
﹤0.01% 386
2024
Q4
$1.46M Hold
2,688,193
0.02% 397
2024
Q3
$2.59M Hold
2,688,193
0.05% 307
2024
Q2
$3.22M Hold
2,688,193
0.07% 259
2024
Q1
$10.2M Hold
2,688,193
0.17% 101
2023
Q4
$1.77M Hold
2,688,193
0.03% 381
2023
Q3
$10.5M Sell
2,688,193
-736,807
-22% -$3.39M 0.23% 112
2023
Q2
$20.6M Buy
3,425,000
+150,000
+5% +$879K 0.37% 58
2023
Q1
$21.7M Buy
3,275,000
+2,450,000
+297% +$20.7M 0.33% 58
2022
Q4
$8.58M Hold
825,000
0.11% 270
2022
Q3
$8.41M Buy
+825,000
New +$8.41M 0.1% 315

Other funds holding OCEA

Polar Asset Management Partners's OCEA Position: Q2 2025 in Review

Polar Asset Management Partners sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 2,688,193 shares — an estimated $142K sold.

Polar Asset Management Partners first reported a position in OCEA in Q3 2022 and held it in 11 quarters. The position peaked at $21.7M in Q1 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Polar Asset Management Partners reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 2,688,193 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $142K.
  • Polar Asset Management Partners first reported a position in Ocean Biomedical, Inc. Common Stock in Q3 2022 and held it in 11 quarters.
  • Polar Asset Management Partners's Ocean Biomedical, Inc. Common Stock position peaked at $21.7M in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.